Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
about
Prediction of the water content in protein binding sitesFrom docking false-positive to active anti-HIV agent.Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoringDiscovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structures.Polarization Effects for Hydrogen-Bonded Complexes of Substituted Phenols with Water and Chloride IonEfficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.Discovery of dimeric inhibitors by extension into the entrance channel of HIV-1 reverse transcriptaseMethyl effects on protein-ligand bindingIdentification of HIV inhibitors guided by free energy perturbation calculations.Optimization of azoles as anti-human immunodeficiency virus agents guided by free-energy calculations.Efficient drug lead discovery and optimization.Energetics of displacing water molecules from protein binding sites: consequences for ligand optimizationEnhanced Monte Carlo Sampling through Replica Exchange with Solute TemperingComputer-aided discovery of anti-HIV agents.Predicting Molecular Targets for Small-Molecule Drugs with a Ligand-Based Interaction Fingerprint Approach.
P2860
Q30495095-2750C9A9-FFEE-447E-BD9B-8F12B43E6EECQ33301713-E02E5989-681F-4C4E-B320-83CDA2039BA4Q33303221-A1A8088E-1DF8-4A33-95BD-96397680007AQ33635679-4770B61C-FFB5-45AC-9BD4-8F3DC02CDBBEQ34373691-D530683C-13AB-4C52-B705-1B748DD7E3EDQ35243844-7847118B-EEC3-4001-8E65-B9B691F05787Q35753013-97607FD0-5EEC-485B-B3C2-E2433BFC55D8Q35963565-B344938D-C0AC-47A1-88C8-BFFC3D17BE60Q36708826-BD90ABCB-68CA-4258-89A6-CD7760795552Q37181622-12A2300D-C9B2-4F1C-A9D1-8863983CD2E0Q37307959-4B25ED92-DDD9-42A7-BD6A-6D4A668C28F0Q37439036-CFFCC4C7-4076-42A9-9A2C-648FCE357E39Q37701321-4F2E5239-F2AE-41CF-B59D-0B0A67B4DDCBQ38916780-9C1A0F28-753F-4A36-A602-2EEA3B54133BQ54256137-7037675E-F3DF-470E-9D0E-88D038AB9ED9
P2860
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@en
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@nl
type
label
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@en
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@nl
prefLabel
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@en
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@nl
P2093
P1476
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
@en
P2093
Andrew D Hamilton
Aravind Basavapathruni
Christopher M Bailey
Joseph T Kim
Juliana Ruiz-Caro
Karen S Anderson
Ligong Wang
P304
P356
10.1016/J.BMCL.2005.10.037
P407
P577
2005-11-17T00:00:00Z